Seres Therapeutics, Inc. (NASDAQ:MCRB) Q3 2019 Earnings Conference Call November 5, 2019 8:30 AM ET Company Participants Carlo Tanzi - Investor Relations Eric Shaff - President and Chief Executive Officer Matt Henn - Chief Scientific Officer Conference Call Participants Chris Shibutani - Cowen and Company Holly Barra - Goldman Sachs Chris Howerton - Jefferies Vernon Bernardino - H.C. Wainwright Operator Ladies and gentlemen, thank you for standing by and welcome to Q3 2019 Seres Therapeutics Earnings Confer ...